POST Online Media Lite Edition


Helsinn Group: William Mann CEO of US operations

Staff writer |
Lugano, Switzerland - September 9, 2009, Lugano, Switzerland - Helsinn Group, a pharmaceutical group, announced that William Mann has been appointed as new CEO in the American subsidiary, Helsinn Therapeutics (U.S.) Inc.

Mr. Mann, PhD, was already Chief Operating Officer of the recently acquired Helsinn Therapeutics, and has held leadership positions in a Swiss multinational with positions in Business Development and in Research. Helsinn also announces that Mr. William Brown has been hired as Vice President Commercial Operations USA, to build a Helsinn Therapeutics direct sales structure in the United States. Mr. Brown has experience in multinational groups and in the management of Supportive Care, having previously managed the product Aloxi in MGI Pha


iOnctura appoints Joanna Horobin as chair
WSSCC names Dominic O'Neill as executive director
Swiss Re appoints Hadi Riachi as India CEO
Credit Suisse appoints Thomas Gottstein as CEO
Primex Pharmaceuticals appoints Dan Spacie as global commercial head

What to read next

LifeCycle Pharma: William J. Polvino new president and CEO
Onvia appoints Russ Mann as new president and CEO
ArborGen: Greg Mann general manager for Australasia